Results For "Theravance-Biopharma"

1 News Found

Theravance Biopharma winds down Ampreloxetine programme after Phase 3 miss

Clinical Trials | March 05, 2026

Theravance Biopharma winds down Ampreloxetine programme after Phase 3 miss

Upcoming E-conference

June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?

July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial

Merck’s experimental cancer drug wins FDA breakthrough status in key lung cancer setting

Glenmark posts strong FY26 results with 27.5% revenue jump

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India

Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India

Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences

Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences

Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India

Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India

Packaging